Fundraising Fox天广实
1 known investors
Find your way into 天广实
Sign up to see every warm intro you have to 天广实
- Paths you didn't know you had: your email and LinkedIn already hold routes to the 天广实 team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
A biopharmaceutical company that develops antibody-based drugs using its own integrated antibody technology platforms, with a pipeline spanning a marketed product and multiple clinical and preclinical candidates. Its therapeutic approaches focus on activating NK cells, redirecting T cells, and modulating other immune cells for conditions such as neuromyelitis optica spectrum disorder (NMOSD) and primary membranous nephropathy (pMN) in China.
Investors · 1
Frequently asked questions
- What does 天广实 do?
- A biopharmaceutical company that develops antibody-based drugs using its own integrated antibody technology platforms, with a pipeline spanning a marketed product and multiple clinical and preclinical candidates. Its therapeutic approaches focus on activating NK cells, redirecting T cells, and modulating other immune cells for conditions such as neuromyelitis optica spectrum disorder (NMOSD) and primary membranous nephropathy (pMN) in China.
- Who are 天广实's investors?
- 天广实's investors include Med-Fine Capital.